Olmesartan-associated enteropathy: New insights on the natural history? Report of two cases

Annalisa Schiepatti, Federico Biagi, Davide Cumetti, Ombretta Luinetti, Aurelio Sonzogni, Amedeo Mugellini, Gino R. Corazza

Research output: Contribution to journalArticle

Abstract

Introduction: The association between olmesartan and an enteropathy histologically indistinguishable from untreated celiac disease has recently been described. However, pathogenetic mechanisms leading to villous atrophy, prevalence, natural history and genetic background of this condition have not yet been defined. Patients: We describe here two cases of olmesartan-associated enteropathy and discuss some aspects of the natural history of this condition. Results: In both patients, an infectious episode seems to have triggered the severe malabsorption syndrome which led them to hospitalization. High titer positive antinuclear antibodies with homogeneous pattern were found. Conclusions: Our reports add to a growing body of evidence suggesting that olmesartan-associated enteropathy should be considered in the presence of villous atrophy and negative celiac serology and in the diagnostic algorithm of non-responsive celiac disease.

Original languageEnglish
Pages (from-to)152-156
Number of pages5
JournalScandinavian Journal of Gastroenterology
Volume51
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Natural History
Celiac Disease
Atrophy
Malabsorption Syndromes
Antinuclear Antibodies
Serology
Abdomen
Hospitalization
olmesartan

Keywords

  • celiac disease
  • enteropathy
  • olmesartan
  • villous atrophy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Olmesartan-associated enteropathy : New insights on the natural history? Report of two cases. / Schiepatti, Annalisa; Biagi, Federico; Cumetti, Davide; Luinetti, Ombretta; Sonzogni, Aurelio; Mugellini, Amedeo; Corazza, Gino R.

In: Scandinavian Journal of Gastroenterology, Vol. 51, No. 2, 01.02.2016, p. 152-156.

Research output: Contribution to journalArticle

@article{3a5d861ba6d44e2da5b986e3cadc144c,
title = "Olmesartan-associated enteropathy: New insights on the natural history? Report of two cases",
abstract = "Introduction: The association between olmesartan and an enteropathy histologically indistinguishable from untreated celiac disease has recently been described. However, pathogenetic mechanisms leading to villous atrophy, prevalence, natural history and genetic background of this condition have not yet been defined. Patients: We describe here two cases of olmesartan-associated enteropathy and discuss some aspects of the natural history of this condition. Results: In both patients, an infectious episode seems to have triggered the severe malabsorption syndrome which led them to hospitalization. High titer positive antinuclear antibodies with homogeneous pattern were found. Conclusions: Our reports add to a growing body of evidence suggesting that olmesartan-associated enteropathy should be considered in the presence of villous atrophy and negative celiac serology and in the diagnostic algorithm of non-responsive celiac disease.",
keywords = "celiac disease, enteropathy, olmesartan, villous atrophy",
author = "Annalisa Schiepatti and Federico Biagi and Davide Cumetti and Ombretta Luinetti and Aurelio Sonzogni and Amedeo Mugellini and Corazza, {Gino R.}",
year = "2016",
month = "2",
day = "1",
doi = "10.3109/00365521.2015.1074719",
language = "English",
volume = "51",
pages = "152--156",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Olmesartan-associated enteropathy

T2 - New insights on the natural history? Report of two cases

AU - Schiepatti, Annalisa

AU - Biagi, Federico

AU - Cumetti, Davide

AU - Luinetti, Ombretta

AU - Sonzogni, Aurelio

AU - Mugellini, Amedeo

AU - Corazza, Gino R.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Introduction: The association between olmesartan and an enteropathy histologically indistinguishable from untreated celiac disease has recently been described. However, pathogenetic mechanisms leading to villous atrophy, prevalence, natural history and genetic background of this condition have not yet been defined. Patients: We describe here two cases of olmesartan-associated enteropathy and discuss some aspects of the natural history of this condition. Results: In both patients, an infectious episode seems to have triggered the severe malabsorption syndrome which led them to hospitalization. High titer positive antinuclear antibodies with homogeneous pattern were found. Conclusions: Our reports add to a growing body of evidence suggesting that olmesartan-associated enteropathy should be considered in the presence of villous atrophy and negative celiac serology and in the diagnostic algorithm of non-responsive celiac disease.

AB - Introduction: The association between olmesartan and an enteropathy histologically indistinguishable from untreated celiac disease has recently been described. However, pathogenetic mechanisms leading to villous atrophy, prevalence, natural history and genetic background of this condition have not yet been defined. Patients: We describe here two cases of olmesartan-associated enteropathy and discuss some aspects of the natural history of this condition. Results: In both patients, an infectious episode seems to have triggered the severe malabsorption syndrome which led them to hospitalization. High titer positive antinuclear antibodies with homogeneous pattern were found. Conclusions: Our reports add to a growing body of evidence suggesting that olmesartan-associated enteropathy should be considered in the presence of villous atrophy and negative celiac serology and in the diagnostic algorithm of non-responsive celiac disease.

KW - celiac disease

KW - enteropathy

KW - olmesartan

KW - villous atrophy

UR - http://www.scopus.com/inward/record.url?scp=84946498563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946498563&partnerID=8YFLogxK

U2 - 10.3109/00365521.2015.1074719

DO - 10.3109/00365521.2015.1074719

M3 - Article

C2 - 26291698

AN - SCOPUS:84946498563

VL - 51

SP - 152

EP - 156

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 2

ER -